BNCM and DELEX Announced Plans for Corporate Name and Ticker Symbol Change
July 19th 2025
Bounce Mobile Systems, Inc.
(OTC: BNCM) and Delex Healthcare Group today announced plans to change the
parent company’s corporate name and ticker symbol.
The proposed name and ticker
symbol change, which will be filed with regulatory authorities by the end of
August 2025, reflects BNCM’s intent to align its public identity with the core
operating businesses of Delex Healthcare Group. The ticker symbol change will
proceed subject to approval by the Financial Industry Regulatory Authority
(FINRA) and other applicable regulatory processes
It is important to note that BNCM has no relationship whatsoever with DELEX
Pharma International, Inc. at this time. BNCM’s affiliation is strictly with
Delex Healthcare Group. Any potential relationship between BNCM and DELEX
Pharma International, Inc. may only proceed upon formal approval by the
Securities and Exchange Commission (SEC) of the Philippines regarding the ownership
structure under DLX Holdings—a process that is still underway and may take time
to finalize.
Paul Hatadi, CEO of Bounce
Mobile Systems, Inc. (BNCM):
“This marks the beginning of a transformative phase for our company. By
aligning our corporate name and ticker symbol with our operating business, we
are sending a clear signal to the market: we are focused, we are growing, and
we are committed to building long-term shareholder value through DELEX Pharma’s
expanding footprint in the healthcare sector.”
J. de Ruyter C. Oroceo, CEO & Chairman of the Board of DELEX Pharma International, Inc., added:
“This change reflects the substance of what DELEX has built and where we are going. We are proud of our roots, and even prouder of the opportunities ahead. As we integrate our vision more closely with our capital market’s identity, we are positioning ourselves for aggressive growth, global partnerships, and increased visibility with institutional investors. The future of DELEX is just beginning.”
The management teams are working closely with legal and compliance advisors to complete the formal transition process. Shareholders will not need to take any action at this time. Further announcements will be made as approvals are secured, and timelines are finalized.
Paul Hatadi has agreed to remain as CEO and his current role including matters related to investor relations and security transfers and management for the next six to twelve months to ensure a smooth transition of the management and operation to the DELEX team.
About Bounce Mobile Systems, Inc. (BNCM)
On July 2nd. 2024, the Board of Directors of Delex Healthcare Group Inc. (DELEX) and Bounce Mobile Systems Inc. (BNCM) has signed an agreement for the merger between DELEX and BNCM.
About Delex Healthcare Group Inc. (DELEX)
DELEX is a leading pharmaceutical company in the Philippines, engaged in the development, marketing, and distribution of a wide range of pharmaceutical and healthcare products. DELEX is committed to providing quality and affordable medicines and medical devices, with a strong focus on critical care, anti-infectives, anesthesia, oncology, and women's health.
For more Information
Email : info@bncm.us
Website : https://bncm.us
Disclaimer: The information presented in this article is for informational
purposes only and does not constitute financial, investment, or business
advice. BNCM and DELEX future plans, projections, and growth strategies are
subject to various risks and uncertainties, and actual results may differ
significantly. Investors should conduct their own research and consult with a
financial advisor before making any investment decisions. BNCM and DELEX are
not responsible for any financial or investment outcomes resulting from the use
of this information.